Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oneview HealthcareASX:ONE 37 Days Sales Outstanding is 92.18 as of Jun. 2026, which is 4% above its 10-year median of 88.45. GuruFocus rates ASX:ONE with a GF Score™ of 37/100 and a GF Value™ of A$0.39 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Oneview Healthcare ranks worse than 82.23% on this metric.
The historical rank and industry rank for Oneview Healthcare's Days Sales Outstanding or its related term are showing as below:
ASX:ONE'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 37.06 Med: 88.45 Max: 233.88
Current: 98.26
During the past 10 years, Oneview Healthcare's highest Days Sales Outstanding was 233.88. The lowest was 37.06. And the median was 88.45.
ASX:ONE's Days Sales Outstanding is ranked worse than 82.23% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 45.78
vs ASX:ONE: 98.26
Oneview Healthcare's Days Sales Outstanding
increased
from Jun. 2025 (84.66) to Jun. 2026 (92.18).
Oneview Healthcare (ASX:ONE) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Oneview Healthcare Days Sales Outstanding Related Terms
Oneview Healthcare Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Oneview Healthcare's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ONE vs VEEV, BTSG, TEM: Days Sales Outstanding Comparison
For the Health Information Services subindustry, Oneview Healthcare's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oneview Healthcare Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oneview Healthcare's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Oneview Healthcare's Days Sales Outstanding falls into.
Oneview Healthcare Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oneview Healthcare (ASX:ONE) has a Days Sales Outstanding of 92.18 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Oneview Healthcare and its competitors. This is near median its historical median of 88.45. Over the past decade, Oneview Healthcare's Days Sales Outstanding has ranged from 37.06 to 233.88. According to the industry distribution chart, Oneview Healthcare ranks #546 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 82.2%.
Is Oneview Healthcare's Days Sales Outstanding too high?
Oneview Healthcare's current Days Sales Outstanding of 92.18 is near median its 10-year median of 88.45. Over the past 10 years, this metric has ranged from a low of 37.06 to a high of 233.88. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.78. Oneview Healthcare's value of 92.18 is 101.4% above this industry median. Based on the distribution chart, Oneview Healthcare ranks #546 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Oneview Healthcare has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oneview Healthcare's Days Sales Outstanding compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Oneview Healthcare ranks #546 out of 664 companies for Days Sales Outstanding. This places Oneview Healthcare in the lower half of its industry. The industry median Days Sales Outstanding is 45.78. Oneview Healthcare's value of 92.18 is 101.4% above this benchmark. Historically, Oneview Healthcare's own Days Sales Outstanding has ranged from 37.06 to 233.88 over the past decade. While the company's 10-year median is 88.45 vs. the industry median of 45.78, Oneview Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.78, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oneview Healthcare's current Days Sales Outstanding of 92.18 is 101.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Oneview Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oneview Healthcare's current Days Sales Outstanding is 92.18, which is near median its own 10-year median of 88.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneview Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Oneview Healthcare (ASX:ONE) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.39, compared to a current price of A$0.17 — trading 57.7% below its estimated fair value. The current Days Sales Outstanding is 92.18, which is near median its 10-year median of 88.45 and 101.4% above the Healthcare Providers & Services industry median of 45.78. Oneview Healthcare's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Oneview Healthcare (ASX:ONE), the current Days Sales Outstanding is 92.18 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oneview Healthcare (ASX:ONE) Overvalued in 2026?
Based on GuruFocus' analysis, Oneview Healthcare stock appears to be undervalued.
The current stock price of A$0.17 is trading 57.7% below its estimated GF Value™ of A$0.39.
GuruFocus considers Oneview Healthcare to be Possible Value Trap.
Key valuation signals for ASX:ONE:
Days Sales Outstanding: 92.18 (near median its 10-year median of 88.45)
GF Value™: A$0.39 vs. price of A$0.17 (57.7% below fair value)
Industry Position: 101.4% above the Healthcare Providers & Services median (#546 of 664)
No single metric tells the full story. See the ASX:ONE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare's Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays. The company operates in one reportable segment, which provides a patient engagement solution for the healthcare sector.
37GF Score
Get the complete analysis for ASX:ONE
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ONE has been successfully added to your 
